BrainStorm Cell Therapeutics Reports Third Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 10/22/2026

6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Brainstorm Cell Therapeutics (BCLI) Tops Q3 EPS by 2c

November 15, 2016 9:19 AM EST

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q3 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

As of September 30, 2016, the Company had cash, cash equivalents, and short-term deposits of approximately $11.2 million.

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.

... More